Activity

espective of rejection characteristics.

The impacts of COVID-19 on lung allograft function, rejection, secondary infection, and clinical outcomes in lung transplant recipients (LTRs) remain unknown.

A 12 matched case-control study was performed to evaluate re-hospitalization, lung allograft function, and secondary infections up to 90 days after COVID-19 diagnosis (or index dates for controls).

Twenty-four LTRs with COVID-19 (cases) and 48 controls were identified. Cases and controls had similar baseline characteristics and lung allograft function. LTRs with COVID-19 had higher incidence of secondary bacterial infection (29.2% vs 6.3%, p = 0.008), readmission (29.2% vs 10.4%, p = 0.04), and for-cause bronchoscopy (33.3% vs 12.5%, p = 0.04) compared to controls. At day 90, mortality in cases vs controls was 8.3 vs 2.1% (p = 0.21), incidence of invasive fungal infections in cases vs controls was 20.8% vs 8.3% (p = 0.13) and forced expiratory volume in 1 second (FEV1) decline ≥ 10% from baseline occurred in 19% of cases vs 12.2% of controls (p= 0.46). No acute cellular rejection, acute antibody mediated rejection, or new donor specific anti-HLA antibodies were observed among cases or controls within 90 days post index date.

We found LTRs with COVID-19 were at risk to develop secondary infections and re-hospitalization post COVID-19, compared to controls. While we did not observe post -viral ACR or AMR, further studies are needed to understand if LTRs with COVID-19 who did not recover baseline lung function within 90 days have developed chronic lung allograft dysfunction stage progression.

We found LTRs with COVID-19 were at risk to develop secondary infections and re-hospitalization post COVID-19, compared to controls. While we did not observe post -viral ACR or AMR, further studies are needed to understand if LTRs with COVID-19 who did not recover baseline lung function within 90 days have developed chronic lung allograft dysfunction stage progression.

Quantitative analysis of the high-resolution T1-weighted images provides useful markers to measure anatomical changes during brain degeneration related to major depressive disorder (MDD). However, there are controversial findings regarding these volume alterations in MDD indicating even to increased volumes in some specific regions in MDD patients.

This study is a case-controlled study including 23 depression patients and 15 healthy subject person and 20-38 years of age, who have been treated at the Neurology and Psychiatry Department here. We compared specific anatomic regions between drug-free MDD patients and control group through MRI-Cloud, which is a novel brain imaging method that enables to analyze multiple brain regions simultaneously.

We have found that frontal, temporal, and parietal hemispheric volumes and middle frontal gyrus, inferior frontal gyrus, superior parietal gyrus, cingulum-hippocampus, lateral fronto-orbital gyrus, superior temporal gyrus, superior temporal white matter, middle temporal gyrus subanatomic regions were significantly reduced bilaterally in MDD patients compared to the control group, while striatum, amygdala, putamen, and nucleus accumbens bilaterally increased in MDD group compared to the control group suggesting that besides the heterogeneity among studies, also comorbid factors such as anxiety and different personal traits could be responsible for these discrepant results.

Our study gives a strong message that depression is associated with altered structural brain volumes, especially, in drug-free and first-episode MDD patients who present with similar duration and severity of depression while the role of demographic and comorbid risk factors should not be neglected.

Our study gives a strong message that depression is associated with altered structural brain volumes, especially, in drug-free and first-episode MDD patients who present with similar duration and severity of depression while the role of demographic and comorbid risk factors should not be neglected.

Numerous neuroimaging studies have demonstrated that functional brain aberrations are associated with cognitive impairments in temporal lobe epilepsy (TLE). Here, we aimed to investigate the neural substrates of attention deficits by combining assessment of regional intrinsic brain activities with large-scale functional connectivity in patients with right TLE (rTLE).

Thirty-five patients with rTLE and 33 matched healthy controls were recruited. All participants completed the Attention Network Test (ANT) and resting-sate functional MRI (rs-fMRI) scans. The z-standardized fractional amplitude of the low-frequency fluctuation (zfALFF) approach was applied to evaluate the brain’s intrinsic activity. The cerebral regions with significant zfALFF values were selected as seeds for subsequent functional connectivity analyses. A correlation analysis was performed between functional activity and clinical variables.

Compared with the healthy control group, the patients showed decreased zfALFF in the right inferior factors in attention deficits, especially further profoundly illuminated the compensatory role of cerebellum in patients with rTLE.

The frequency of lymphogranuloma venereum (LGV) or invasive Chlamydia trachomatis (CT) infection with serovar L1, L2 or L3 is unknown in the United States. While no diagnostic test is commercially available, we used a laboratory-developed test and detected LGV-associated serovar L2 in 14% of 132 remnant CT-positive rectal swabs.

The frequency of lymphogranuloma venereum (LGV) or invasive Chlamydia trachomatis (CT) infection with serovar L1, L2 or L3 is unknown in the United States. While no diagnostic test is commercially available, we used a laboratory-developed test and detected LGV-associated serovar L2 in 14% of 132 remnant CT-positive rectal swabs.

Chlamydia and gonorrhea have increased nationally and in the US Army. Rates reported in the Army are elevated relative to the general population, partly due to differing population demographics.

Age- and sex-specific chlamydia and gonorrhea case rates among Army active component soldiers and the wider 18-64 US adult population were computed from reports submitted through national and military surveillance systems during 2015-2019. Rates were standardized using the 2015 Army age and sex population distribution. Multivariable generalized linear models were generated to evaluate associated risk factors.

Army age-sex adjusted chlamydia rates (per 100,000 person-years) were nearly twice those of US adults (2019 rates 2,317 versus 1,241), whereas US age-sex adjusted gonorrhea rates surpassed Army rates (2019 rates 536 versus 396). Chlamydia and gonorrhea rates were significantly elevated in Army women under 25 relative to US women 18-24 (2015-2019 crude rates 10,404 Army4,243 US for chlamydia, and 1,014 Army6hea rates may reflect differences in high-risk sub groups (e.g., men who have sex with men), differing sexual networks, or other confounders.

We report on hepatitis C virus genotype 2c infection in 12 human immunodeficiency virus-infected men who have sex with men in Tokyo, Japan. The uncommon strains from the 12 patients were genetically clustered; they suggested an emerging outbreak in this population at high risk of sexually transmitted infections.

We report on hepatitis C virus genotype 2c infection in 12 human immunodeficiency virus-infected men who have sex with men in Tokyo, Japan. The uncommon strains from the 12 patients were genetically clustered; they suggested an emerging outbreak in this population at high risk of sexually transmitted infections.

Despite progress in the treatment of childhood acute lymphoblastic leukemia, severe complications are common, and the need of supportive care is high. We explored the cumulative prevalence, clinical risk factors, and outcomes of children with acute lymphoblastic leukemia, on first-line leukemia treatment in the ICUs in Sweden.

A nationwide prospective register and retrospective chart review study.

Children with acute lymphoblastic leukemia were identified,and demographic and clinical data were obtained from the Swedish Childhood Cancer Registry. Data on intensive care were collected from the Swedish Intensive Care Registry. Data on patients with registered ICU admission in the Swedish Childhood Cancer Registry were supplemented through questionnaires to the pediatric oncology centers.

All 637 children 0-17.9 years old with acute lymphoblastic leukemia diagnosed between June 2008 and December 2016 in Sweden were included.

None.

Twenty-eight percent of the children (178/637) were admitted to an ICU S leukemia, is high with most admissions occurring during early treatment.

The aim of this study was to test whether a physician-supervised web-based app, integrated with an electronic medical record, helps in improving blood pressure (BP) management in clinical practice.

An observational study of 1633 patients seen at a hypertension clinic managed by an endocrinologist with two cohorts (726 adopted the app and 907 had not). D-1553 inhibitor The app allowed patients and doctors to monitor BP, blood sugar and other vital signs. Patients decided whether to opt in to using the app and how often to upload their readings. The provider could offer feedback and communicate with patients through the app. We evaluated the change in office-based BP measurement before and after app adoption (at least 12 months apart). We performed a difference-in-difference analysis along with matching based on patient-individual characteristics.

The difference-in-difference estimates were 6.23 mmHg systolic [95% confidence interval (95% CI) 0.87-11.59] for patients with SBP 150 mmHg or above, 4.01 mmHg systolic (95% CI 1.11-6.91) for patients with SBP 140 mmHg or above, 4.37 mmHg diastolic (95% CI 1.06-7.68) for patients with DBP 90 mmHg or above, 1.89 mmHg systolic (95% CI 0.58-3.2) and 0.87 mmHg diastolic (95% CI 0.17-1.57) overall for an average patient. Higher frequency of app usage was also associated with a greater reduction in BP.

Use of an mHealth app in a clinical practice, was associated with a significant reduction in BP for average patients as well as high-severity patients. Physician-supervised mHealth apps in a clinical practice could be instrumental in managing patient BP.

Use of an mHealth app in a clinical practice, was associated with a significant reduction in BP for average patients as well as high-severity patients. Physician-supervised mHealth apps in a clinical practice could be instrumental in managing patient BP.

The COVID-19 pandemic reshaped the healthcare system in 2020. COVID-19 infection has been associated with poor outcomes after orthopedic surgery and elective, general surgery, but the impact of COVID-19 on outcomes after trauma is unknown.

We conducted a retrospective cohort study of patients admitted to Pennsylvania trauma centers from March 21-July 31, 2020. The exposure of interest was COVID-19 (COV +) and the primary outcome was inpatient mortality. Secondary outcomes were length of stay and complications. We compared demographic and injury characteristics between positive, negative, and not-tested patients. We used multivariable regression with coarsened exact matching to estimate the impact of COV+ on outcomes.

Of 15,550 included patients, 8,170 (52.5%) were tested for COVID-19 and 219 (2.7%) were positive (COV+). Compared to COVID-19 negative (COV-) patients, COV+ patients were similar in terms of age and sex, but were less often white (53.5% vs. 74.7%, p < 0.0001), and more often uninsured (10.